ArticleOncology letters2025

SBEM confers paclitaxel resistance in breast cancer via DUSP16-mediated MAPK/AMPK pathway activation.

Liang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.